The Acid Ceramidase Is a SARS-CoV-2 Host Factor

SARS-CoV-2 variants such as the delta or omicron variants, with higher transmission rates, accelerated the global COVID-19 pandemic. Thus, novel therapeutic strategies need to be deployed. The inhibition of acid sphingomyelinase (ASM), interfering with viral entry by fluoxetine was reported. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, Nina, Kersting, Louise, Schlegel, Jan, Stelz, Linda, Fähr, Sofie, Diesendorf, Viktoria, Roll, Valeria, Sostmann, Marie, König, Eva-Maria, Reinhard, Sebastian, Brenner, Daniela, Schneider-Schaulies, Sibylle, Sauer, Markus, Seibel, Jürgen, Bodem, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406565/
https://www.ncbi.nlm.nih.gov/pubmed/36010608
http://dx.doi.org/10.3390/cells11162532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406565/
https://www.ncbi.nlm.nih.gov/pubmed/36010608
http://dx.doi.org/10.3390/cells11162532

Ejemplares similares